Sanofi (SNY) Asset Writedowns and Impairment (2010 - 2023)
Sanofi (SNY) posted Asset Writedowns and Impairment of $16.1 million for Q1 2023, up 186.9% sequentially from $5.6 million in Q1 2022, and up 186.9% YoY from $5.6 million in Q1 2022.
Sanofi (SNY) Asset Writedowns and Impairment (2010 - 2023) Analysis & Trends
Sanofi (SNY) has 8 years of Asset Writedowns and Impairment data on file, last reported at $16.1 million in Q1 2023.
- Quarterly Asset Writedowns and Impairment rose 186.9% year-over-year to $16.1 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$795.0 million (up 2.12% YoY) and the FY2016 annual result came in at $505.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment advanced to $16.1 million in Q1 2023 per SNY's latest filing, from $5.6 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $16.1 million in Q1 2023, with the low at $5.6 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Sanofi | - | - | 9.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 16.10 Mn |
| Mar 31, 2023 | 16.10 Mn |
| Mar 31, 2022 | 5.61 Mn |
| Mar 31, 2022 | 5.61 Mn |
| Dec 31, 2015 | -584.23 Mn |
| Dec 31, 2015 | -584.23 Mn |
| Sep 30, 2015 | -232.47 Mn |
| Sep 30, 2015 | -232.47 Mn |
| Jun 30, 2015 | -1.11 Mn |
| Jun 30, 2015 | -1.11 Mn |
| Dec 31, 2014 | 168.73 Mn |
| Dec 31, 2014 | 168.73 Mn |
| Sep 30, 2014 | 46.46 Mn |
| Sep 30, 2014 | 46.46 Mn |
| Jun 30, 2014 | 97.40 Mn |
| Jun 30, 2014 | 97.40 Mn |
| Dec 31, 2013 | -1.25 Bn |
| Dec 31, 2013 | -1.25 Bn |
| Sep 30, 2013 | 37.10 Mn |
| Sep 30, 2013 | 37.10 Mn |